VS

Vijay Satyanarayan Khandelwal

Active Director Designated Partner DIN 10401456
DIN 10401456 First appointment Nov 2023 Primary industry Business Services
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Nov 2023
Shareholding value β€’β€’β€’β€’ Premium profile

About Vijay Satyanarayan Khandelwal

Data last updated:

Vijay Satyanarayan Khandelwal is a Designated Partner at Govinda Pharma Llp (since 2023). The company operates in Business Services.

DIN 10401456
Primary Designation Designated Partner
Industry Business Services
First Appointment 22 Nov 2023
Oldest Company Age 2 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Designated Partner22 Nov 20232023Active

Board colleagues of Vijay Satyanarayan Khandelwal

NameDINCompanyDesignation
Devesh Subhashrao Gangane10401458Govinda Pharma LlpDesignated Partner

Directorship timeline

Open interactive timeline →
Govinda Pharma Llp
Premium access

Shareholding and investment profile for Vijay Satyanarayan Khandelwal

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Vijay Satyanarayan Khandelwal

Vijay Satyanarayan Khandelwal currently holds 1 directorship: Govinda Pharma Llp (Designated Partner, since 22 Nov 2023).

Vijay Satyanarayan Khandelwal was first appointed on 22 Nov 2023 as Designated Partner at Govinda Pharma Llp.

The current boards of Vijay Satyanarayan Khandelwal's companies include Devesh Subhashrao Gangane (Govinda Pharma Llp).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available